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Interleukin-1 (IL-1) receptor signaling is necessary for
control of Mycobacterium tuberculosis (Mtb) infec-
tion, yet the role of its two ligands, IL-1a and IL-1b,
and their regulation in vivo are poorly understood.
Here, we showed that both IL-1a and IL-1b are
critically required for host resistance and identified
two multifunctional inflammatory monocyte-macro-
phage and DC populations that coexpressed both
IL-1 species at the single-cell level in lungs of Mtb-
infected mice. Moreover, we demonstrated that
interferons (IFNs) played important roles in regu-
lating IL-1 production by these cells in vivo. Type I
interferons inhibited IL-1 production by both subsets
whereas CD4+ T cell-derived IFN-g selectively sup-
pressed monocyte-macrophages. These data pro-
vide a cellular basis for both the anti-inflammatory
effects of IFNs and probacterial functions of type I
IFNs during Mtb infection and reveal differential
regulation of IL-1 production by distinct cell popula-
tions as an additional layer of complexity in the
activity of IL-1 in vivo.
INTRODUCTION
Mycobacterium tuberculosis (Mtb) primarily infects mononuclear
phagocytes. Host resistance against this important pathogen is
critically dependent on innate immune functions exerted by
these cells including the production of inducible nitric oxide syn-
thase (iNOS), TNF-a, and IL-12,23 p40 (Cooper et al., 2011;
North and Jung, 2004). More recently, it has become clear that
IL-1 is also of critical importance for host control ofMtb infection
given that mice deficient in IL-1R or its adaptor MyD88 succumb
rapidly to low-dose aerosol infection with Mtb (Fremond et al.,
2007; Mayer-Barber et al., 2010). Although we have shown that
IL-1R-dependent protection requires IL-1b (Mayer-Barber
et al., 2010), the contribution of IL-1a, the secondmajor cytokine
agonist for this receptor, has been unclear.
A major feature of IL-1 is its complex control at the transcrip-
tional, posttranscriptional, and signal transduction levels, whichImmis highlighted by the wide variety of immunopathologies and
autoinflammatory diseases that occur in the absence of normal
IL-1 regulation (Dinarello, 2009, 2010; Garlanda et al., 2007).
Surprisingly little is known about the expression and processing
of IL-1 in the context of Mtb infection in vivo. Whereas IL-1b
production in response to Mtb in vitro is dependent on the
NALP3-ASC inflammasome, we and others have recently re-
ported that in lungs ofMtb-infected mice, cleaved IL-1b is found
even in the absence of the critical inflammasome component
caspase-1. Moreover, although IL-1b is absolutely critical
for host control of Mtb infection in mice, NLRP3, ASC, or
caspase-1 play minor roles in host resistance to this pathogen
(Mayer-Barber et al., 2010; McElvania Tekippe et al., 2010;
Walter et al., 2010). Although it is not clear what factors mediate
the processing of IL-1b during Mtb infection in vivo, the inflam-
masome independence of the IL-1b response may indicate
that it is produced by an atypical cellular source with unique
IL-1b-processing properties. For example, the neutrophils
present in arthritic joints have been shown to be both a key
producer of the cytokine and to cleave IL-1b in a caspase-1-
independent manner (Guma et al., 2009; Joosten et al., 2009).
The cell populations that produce host-protective IL-1 during
Mtb infection in vivo, however, have not yet been characterized.
Type II interferon, IFN-g, is the signature cytokine of T helper 1
(Th1) cells and has well-established protective functions in host
resistance toMtb and other mycobacterial infections inmice and
humans. IFN-g is traditionally regarded as a proinflammatory
cytokine and its protective function duringMtb infection involves
the activation of macrophage (Flynn and Chan, 2001). In con-
trast, the role of type I IFN in the immune response to virulent
Mtb is less clear and even though type I and II IFNs share similar
STAT1-dependent signaling pathways, type I IFNs appear to
promote rather than control infection. Thus, the hypervirulence
of certain Mtb strains correlates with enhanced type I IFN syn-
thesis and type I IFN receptor-deficient mice infected with Mtb
display lower bacterial loads when compared to WT animals
(Manca et al., 2001; Stanley et al., 2007). In addition, Mtb-
infected mice intranasally treated with the type I IFN inducer
polyinosinic-polycytidylic acid stabilized with poly-L-lysine
(pICLC) exhibit exacerbated lung pathology and increased
bacterial burden (Antonelli et al., 2010). The relevance of these
observations to human tuberculosis is supported by a recent
study in which the whole blood transcriptional profile of TB
patients was found to be dominated by type I and II IFN-inducedunity 35, 1023–1034, December 23, 2011 ª2011 Elsevier Inc. 1023
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Figure 1. Mtb-Infected Il1a–/– Mice Display Acute
Mortality and Elevated Bacterial Loads Compa-
rable to Il1b–/– Animals
(A) Bodyweight and survival ofWT, Il1r1/, Il1a/Il1b/,
Il1b/, and Il1a/ mice after aerosol exposure to Mtb
(H37Rv).
(B) Bacterial loads measured 25 days p.i. in lungs of the
above mouse strains.
(C) Indicated cytokines were measured by ELISA in BAL
fluid of WT (white bars), Il1r1/ (black bars), Il1a/Il1b/
(dark-gray bars), Il1b/ (light-gray bars), and Il1a/ (gray
and white striped bars) mice and the means ± SD
depicted. Dotted lines indicate the limits of detection of the
respective assays. Data are representative of a minimum
of two independent experiments each involving five to ten
mice per group. The asterisk denotes significant (p% 0.05)
differences compared to WT controls.
Immunity
IFNs Limit IL-1 Production during Tuberculosisgenes, and this signature closely correlated with disease severity
(Berry et al., 2010). Nevertheless, the cellular mechanisms by
which type I IFNs mediate their probacterial effects inMtb infec-
tion and whether or not they involve crosstalk with other innate
cytokine pathways remains unclear.
Here, we establish that IL-1a and IL-1b (IL-1a,b) each had
critical functions in murine host resistance against Mtb and
identified and characterized the two major myeloid subsets
that produce both cytokines in the lungs of Mtb-infected mice
as inflammatory monocyte-macrophages (iMs) and DCs (iDCs)
with highly polyfunctional properties. Importantly, we demon-
strated that the endogenous type I IFN was a potent negative
regulator of IL-1a,b production by both of these myeloid cell
populations. In addition, our data revealed an anti-inflammatory
role for CD4+ T cell-derived IFN-g in dampening IL-1 expression
by iMs. Together, these findings established polyfunctional
mononuclear phagocytes as the major myeloid source of IL-1
during Mtb infection and provided a cellular basis for the cross-
talk between IFNs and IL-1 in the immune response to this
bacterial pathogen in vivo.1024 Immunity 35, 1023–1034, December 23, 2011 ª2011 Elsevier Inc.RESULTS
IL-1a and IL-1b Are Each Critical for Host
Resistance to Mtb
To investigate the respective contributions of the
two ligands IL-1aand IL-1b in IL-1R1-dependent
host resistance toMtb, we performed a series of
experiments directly comparing the suscepti-
bility of Il1r1/, Il1a/Il1b/, Il1b/, and
Il1a/mice to low-dose aerosol (100–150 CFU)
infection. As described previously (Mayer-
Barber et al., 2010), IL-1R1- and IL-1b-deficient
mice rapidly lost weight and succumbed within
40 days (Figure 1A). No further increase in
susceptibility was evident in mice doubly defi-
cient in both IL-1a and IL-1b. Importantly, mice
deficient in IL-1a alone displayed similar weight
loss and mortality as Il1r1/, Il1a/Il1b/, or
Il1b/ mice and showed increased bacterial
loads equivalent to that of infected Il1b/
animals (Figures 1A and 1B). Moreover, weobserved similar amounts of IL-1b in the lungs of WT and IL-1a
single-deficient mice and conversely comparable amounts of
IL-1a in WT and IL-1b-deficient animals (Figure 1C). IL-1a and
IL-1b singly deficient animals each exhibited lower bacterial
counts than Il1r1/ or Il1a/Il1b/ mice, highlighting a dual
requirement for both IL-1 species and suggesting a possible
synergy in the antibacterial function of the two cytokines. Indeed,
when infected with a lower dose (<50 CFU) of Mtb, both Il1a/
and Il1b/mice survived longer than Il1r1/ animals (Figure S1
available online). Taken together, these observations argue that
IL-1a and IL-1b each have critical nonredundant functions and
cooperate in IL-1R1-mediated host resistance to Mtb.
IL-1a and IL-1b Are Coexpressed by CD11bpos Cells in
the Lungs of Mtb-Infected Mice
Studies in which we measured IL-1a,b proteins in lung homoge-
nates of Mtb-infected mice indicated that the cytokines are
induced during the acute phase beginning at 2 weeks and
peak at 3–4 weeks postinfection (p.i., data not shown). For this
reason we chose d25-d28 as the time point for cellular analysis
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Figure 2. IL-1a and IL-1b Are Coexpressed by Two Pulmonary CD11bpos Populations, Distinguished by Ly6C, CD11c, CD13 and CD282
Expression during Mtb Infection
(A) Pulmonary single-cell suspensions from mice at 4 weeks p.i. were FACS sorted on the basis of Ly6G and CD11b expression into three populations and
subsequently stimulated for 18 hr with H37Rv (Mtb) or left unstimulated (unst.). Data shown are means ± SD of IL-1a and IL-1b in culture supernatants.
(B) Lung cells from naive mice or mice at 4 weeks p.i. were stimulated for 5 hr with (5hr Mtb) or without (unst.) H37Rv and then stained intracellularly for IL-1a and
IL-1b. Numbers indicate mean percentage (±SD) of IL-1 producing cells in depicted gate.
(C) Data depict the mean number of IL-1 producing (±SD) cells per lung at various time points after infection.
(D) CD68 staining of IL-1 producing cells and use of Ly6C and CD11c for further subsetting (numbers indicate percentage of respective population in depicted
gate ± SD).
(E) Proportion of IL-1a,b coproducing cells 4 weeks p.i. in each subset after restimulation for 5 hr with (Mtb, dark circles) or without (unst., white circles) H37Rv.
Each connecting line depicts an individual animal.
(F) CD282 and CD13 expression in correlation with CD11c and IL-1a. Numbers indicate percentage of IL-1-producing cells in depicted gate after restimulation for
5 hr with Mtb.
Data in all panels are representative of a minimum of two experiments with three to ten mice each.
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IFNs Limit IL-1 Production during Tuberculosisof IL-1 production in our studies. Initial experiments utilizing
Il1a,Il1b//WT BM chimeras confirmed a requirement for
hematopoietic cell-derived IL-1 in host resistance (data not
shown). Ex vivo cell sorting experiments fromMtb-infected lungs
were then performed 4 weeks p.i. for assessing IL-1 production
by hematopoietic cells of which mononuclear phagocytes and
neutrophils are the major candidates for production of the
cytokine in vivo. We generated lung single-cell suspensions
and FACS sorted non-T and -B cells into CD11bneg cells,
Ly6GhiCD11bhi neutrophils, and Ly6GnegCD11bpos cells and
stimulated the cells overnight in the presence or absence of
live Mtb. IL-1a,b production was found to be largely confined
to the Ly6Gneg CD11bpos sorted fraction, whereas neutrophils
generated little and Ly6GnegCD11bneg cells undetectable
amounts of IL-1 (Figure 2A).
To analyze IL-1 production at the single-cell level, we per-
formed intracellular cytokine staining (ICS) of cells from digested
lung. Importantly, we observed strong IL-1a,b staining in cells
derived from 4 weeks infected but not naive lungs after 5 hrImmex vivo restimulation with irradiated (or live) H37Rv (Figure 2B
and data not shown). The latter observation argues that the
potential for IL-1 expression by pulmonary CD11bpos cells is
acquired in the context of Mtb infection in vivo probably via
changes in cellular composition, recruitment, and activation
status, rather than through the 5 hr restimulation per se. Consis-
tent with the above findings on FACS isolated cell populations,
Ly6Gneg CD11bpos cells expressed the most IL-1a,b by intracel-
lular staining, whereas neutrophils from infected lungs stained
weakly for IL-1a but not IL-1b and CD11bneg cells were negative
for both cytokines (Figure 2B and data not shown). Importantly,
the ICS analysis revealed that in the Ly6Gneg CD11bpos popula-
tion IL-1a and IL-1b are coexpressed at the single-cell level.
Moreover, in the early stages of infection, the kinetics of the
appearance of pulmonary IL-1a,b double-positive (IL-1a, bDP)
Ly6Gneg CD11bpos cells closely mirrored the cytokine proteins
measured by ELISA in lung homogenates of infected mice
(Figures 2C and data not shown). Together, these data show
that Ly6Gneg CD11bpos cells and not neutrophils are the majorunity 35, 1023–1034, December 23, 2011 ª2011 Elsevier Inc. 1025
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IFNs Limit IL-1 Production during Tuberculosishematopoietic source of IL-1 in the lungs of infected mice and
that this population coordinately expresses IL-1a,b at the cellular
level.
The IL-1a,b-Producing Cells in the Lungs of Mtb-
Infected Mice Consist of Two Major Populations
Distinguishable by Their Expression of CD11c and Ly6C
To discriminate between myeloid versus lymphoid CD11bpos
cells, we included the intracellular macrophage-myeloid marker
CD68 (Figures 2D and S2A) and found that 4 weeks p.i. 30%–
40% (31% ± 8%) of pulmonary Ly6GnegCD11bpos cells were of
nonmyeloid origin, such as NK and T cells (Figure 2D). This
analysis revealed that within the CD11bpos population IL-1a,b
expression is restricted to CD68pos cells (Figure 2D and data
not shown). Moreover, CD68pos, CD11bpos myeloid cells segre-
gated into two populations based on differential CD11c and
Ly6C expression, with the CD11cpos subset expressing varying
degrees of Ly6C (referred to as iDC cells) while the CD11cneg
cells displayed uniformly high expression of Ly6C (referred to
as iM cells) (Figures 2D–2F). Importantly, the IL-1a,b-coproduc-
ing cells also dissociated into the same two populations based
on CD11c and Ly6C expression (Figures 2D and 2E and data
not shown). In addition to CD11c itself, we observed that
IL-1a,bDP pulmonary iDC cells can also be distinguished from
iM cells by their high expression of CD13 (aminopeptidase N)
and CD282 (TLR2) (Figure 2F and data not shown).
Further phenotypic characterization revealed that iM cells
display striking homogeneity with unimodal expression of all
markers screened and thus probably represent a single popula-
tion (Figure S2). In contrast, expression of most markers by the
iDC cells was heterogeneous, suggesting the presence of
multiple subpopulations. iDC cells, when compared to iM cells,
also displayed higher expression of markers associated with
antigen presentation, suggesting that the iDC subsets con-
sists of multiple DC populations (Figures S2B and S2C). iDC
IL-1a,b-expressing cells represent one such subpopulation
displaying a unique phenotype characterized by selective upre-
gulation of CD14, CD206, CD210, CD64, CD30L, CD70, and
CD38 among others (Figures 2B–2D). Of note, we found that
both CD11bpos subsets expressed the ligand-binding chain of
the IFN-g receptor (CD119, IFN-gR1) as well as IFN-inducible
markers such as Ly6C, PD-L1,MHCclass I+II, Sca-1, Fcg recep-
tors (Figures S2B and S2D), and STAT1 phosphorylated at
tyrosine 701 (Figure S2E), arguing that both cell populations
are subject to IFN-mediated signals in vivo duringMtb infection.
Through our findings, we identified two distinct pulmonary
CD11bposCD68pos myeloid subsets on the basis of Ly6C and
CD11c expression that are capable of coproducing both IL-1a
and IL-1b at the single-cell level after Mtb infection.
Pulmonary IL-1a,b Expressing Myeloid Cells
Are Multifunctional but Distinct from
IL-12,23p40-Producing Cells during Mtb Infection
We next functionally characterized the two IL-1a,bDP CD11bpos
myeloid populations present in the Mtb infected lung for their
ability to produce TNFa, iNOS, IL-10 and IL-12,23p40, mediators
previously shown to play important roles in host resistance to the
pathogen (Cooper et al., 2011; Redford et al., 2011). The iM
cells were found to produce TNFa, iNOS and IL-10 but not1026 Immunity 35, 1023–1034, December 23, 2011 ª2011 Elsevier InIL-12,23p40. In contrast, robust IL-12,23p40 as well as TNFa,
iNOS, and IL-10 production was observed in iDC cells (Figures
3A–3D). To determine whether expression of these mediators
correlates with IL-1 production, we costained the same popula-
tions for IL-1a,b. In both populations, iNOS, TNF-a, and IL-10
expression was largely restricted to IL-1a,b DP cells (Figures
3B–3D and data not shown). Importantly, within the iDC subset,
IL-1a,b DP cells failed to make IL-12,23p40, which was instead
produced by a separate functionally distinct DC subpopulation
(Figures 3B–3D and data not shown). Thus, IL-1-producing
myeloid cells in the lungs of Mtb-infected mice display a high
degree of functional heterogeneity at both the population and
single-cell level and are key producers of the antimycobacterial
effector molecules iNOS and TNF-a. Taken together, the above
phenotypic and functional analyses provided a platform for
investigating the regulation of IL-1a,b cytokine production by
myeloid cells at the cellular level during Mtb infection in vivo
(Figure S5A).
IFNs Negatively Regulate the IL-1 Pathway in
Mtb-Infected Mouse and Human Mononuclear
Phagocytes In Vitro
Type I and type II IFNs have been implicated in the regulation of
the IL-1 pathway in vitro as well as in autoimmune and infectious
diseases (Hu et al., 2005; Schindler et al., 1989; Thacker et al.,
2010; Tilg et al., 1993). As noted above, the major IL-1a,b-pro-
ducing subsets in Mtb-infected mice exhibited upregulated
expression of IFN-inducible markers and displayed STAT1 phos-
phorylation. These observations suggested the possible involve-
ment of type I IFN and IFN-g signaling in regulating IL-1 expres-
sion in the response of myeloid cells to Mtb infection.
To study the effects of type I and type II IFNs on IL-1a,b
production in the context of Mtb, we first compared the IL-1a,b
response of murine and human mononuclear phagocytes
exposed in vitro toMtb in the presence or absence of IFNs (Fig-
ure 4). We found that pICLC-induced type I IFN and recombinant
IFN-g potently inhibited IL-1a,b cytokine production by murine
bone marrow-derived macrophages (BMMFs) after Mtb expo-
sure (Figures 4A and 4B). In contrast, in bone marrow-derived
dendritic cells (BMDCs), IL-1a,b were suppressed by IFN-g but
not pICLC. As expected, pICLC significantly inhibited IL-1
production by Ifngr1/ but not Ifnar1/ BMMFs and in addi-
tion, IFNs did not universally downregulate proinflammatory
cytokines given that TNF-a protein was upregulated in the pres-
ence of pICLC and IFN-g in both cell types (data not shown).
IL-27, which also utilizes STAT1 for signal transduction, was
unable to inhibit IL-1 expression, arguing that the suppressive
effects of IFNs reflect specific functions of the latter cytokines
rather than STAT1 activation per se (Figure 4A).
In order to test the relevance of these observations to theMtb
response of humans, we infected monocyte-derived macro-
phages (MFs) or monocyte-derived DCs from 21 healthy blood
donors with Mtb and assessed their ability to generate IL-1a,b
in the presence or absence of IFNs. In agreement with a recent
study from our group focusing on differences in IL-1b regulation
in virulent versus avirulent mycobacteria in human monocytes-
macrophages (Novikov et al., 2011), we found that IFN-b inhibits
production of the former cytokine in macrophages. Here, we
show that in Mtb-infected DCs as well as MF pICLC and IFN-bc.
p40
IL
-1
α
iNOS IL-10
Ly
6C
hi
 
CD
11
cn
e
g
 
CD
11
cp
os
TNFα
iN
O
Sp
os
 
(%
)
IL
-1
0p
os
 
(%
)
IL
-1
2,
23
p4
0p
os
 
(%
)
Mtb
50
40
30
20
10
0
unst.
TN
Fα
po
s  
(%
)
40
30
20
10
0
50
60
Mtbunst.
20
15
10
5
0
Mtbunst.
20
15
10
5
0
Mtbunst.
50
40
30
20
10
0
20
15
10
5
0
20
15
10
5
0
40
30
20
10
0
50
60
CD11cpos
+
+
+
+
+
+
+
+ +
+
+
+
IL-1α,β
TNFα
iNOS
30
10
0
40
20
lung d28 p.i.
5hr Mtb restim
+
+
+
+
+
+
+
+ +
+
+
+
15
5
0
20
10
lung d28 p.i.
5hr Mtb restim
Pe
rc
e
n
t c
yt
ok
in
e 
po
sit
ive
 (%
)
Ly6Chi CD11cneg
Pe
rc
e
n
t c
yt
ok
in
e 
po
sit
ive
 
w
ith
in
 IL
-1
α
po
s 
(%
)
40
80
20
0
60
p4
0
iN
O
S
IL
-1
0
TN
Fα
IL
-1
β
100
CD11cpos
Ly6Chi CD11cneg
Ly
6C
hi
 
CD
11
cn
e
g
 
CD
11
cp
os
Mtbunst. Mtbunst. Mtbunst. Mtbunst.
40
80
20
0
60
100
p4
0
iN
O
S
IL
-1
0
TN
Fα
IL
-1
βPe
rc
e
n
t c
yt
ok
in
e 
po
sit
ive
 
w
ith
in
 IL
-1
α
po
s 
(%
)
Pe
rc
e
n
t c
yt
ok
in
e 
po
sit
ive
 (%
)
iN
O
Sp
os
 
(%
)
IL
-1
0p
os
 
(%
)
IL
-1
2,
23
p4
0p
os
 
(%
)
TN
Fα
po
s  
(%
)
IL-1α,β
TNFα
iNOS
A
B
C D
Figure 3. IL-1a,b Coexpressing Cells in the Lungs of Mtb-Infected
Mice Are Highly Polyfunctional but Distinct from IL-12,23 p40-
Producing Cells
(A–D) Quantitative and qualitative analysis of cytokine production in indicated
subsets 28 days after Mtb infection of WT mice.
(A) Frequencies of iNOS-, TNF-a-, IL-10-, and IL-12,23p40-expressing cells
within iM (top) and iDC (bottom) cell subsets after restimulation for 5 hr with
(Mtb, dark circles) or without (unst., white circles) H37Rv determined by ICS.
Each connecting line depicts an individual animal.
(B) Costaining of IL-1a with indicated cytokines and iNOS.
(C) Percentage of cytokine-producing cells within IL-1a-expressing cells of the
iM (top) or iDC (bottom) cell subset.
(D) Simultaneous analysis of the functional profile of pulmonary iM (top) and
iDC (bottom) cell subsets afterMtb infection on the basis of IL-1a, IL-1b, iNOS,
and TNF-a expression. All combinations of the possible cytokine expression
patterns aremarked on the x axis, whereas the percentages (mean ± SD) of the
distinct cytokine-producing subsets within iM or iDC cells are shown on the
y axis. The data are summarized in pie charts and each slice corresponds to
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Immsuppress both IL-1a and IL-1b and that IFN-g inhibits IL-1b but
not IL-1a production (Figures 4C). Despite the statistically signif-
icant suppression in IL-1b by IFN-g, there was a substantial frac-
tion of donors that responded to Mtb infection with lower
amounts of IL-1b (52% % 4 ng/ml (MF), 8 ng/ml (DC):low
responders; LR), and in these individuals little to no additional
reduction in IL-1b protein was observed after IFN-g treatment
(MF: 29.6% ± 23.4% reduction in LR; 66.9% ± 13.4% reduction
in high responders [HRs]; DCs: 38.5% ± 30.1% reduction in
LR;78.7% ± 0.2% reduction in HR), whereas pICLC or IFN-b
treatment potently suppressed IL-1b by both LR and HR
(>70% ± 5%; Figure 4C and data not shown). This donor varia-
tion may explain the divergent results in our previous study
(Novikov et al., 2011) in which we failed to observe suppression
of IL-1b by IFN-g in human macrophage.
In the murine as well as human systems, we observed upregu-
lation of IL-1R antagonist (IL-1Ra) in a dose-dependent manner
by type I and II IFNs in each cell typewith the exception of murine
DCs (Figure 4D and data not shown). Thus, in both murine and
human mononuclear phagocytes, IFNs antagonize the IL-1
pathway by dual mechanisms: first by directly suppressing
IL-1a,b cytokine production and second by upregulation of the
soluble endogenous IL-1Ra, which opposes IL-1 by competing
for IL-1R1 binding.
Whenwe investigated possible sources of type I IFN, we found
that both murine BMMFs and BMDCs generated detectable
amounts of IFN-b in response Mtb infection (Figure 4E). Type I
IFNs are potent inducers of IL-10 (Chang et al., 2007) and
IL-10 has recently been reported to mediate type I IFN’s
suppressive effects on IL-1 (Guarda et al., 2011). In the context
of Mtb infection in vitro, we observed that IL-10 production is
critically dependent on IFN-aR signaling and that IL-10 is
induced by IFN-b and pICLC in a dose-dependent manner in
BMMFs and BMDCs (Figures 4E and 4F and data not shown).
To investigate the contribution of IL-10 in type I IFN-mediated
suppression of IL-1 duringMtb infection in vitro, we added exog-
enous IL-10 toMtb-infected BMDMs and observed a significant
inhibition of IL-1b production (Figure 4G). More importantly, the
Mtb-induced IFN-b-mediated suppression of IL-1b was partially
reversed when endogenous IL-10 was neutralized (Figure 4H).
Thus in vitro, besides direct suppressive effects, type I IFNs
can also indirectly inhibit IL-1 production during Mtb infection
via IFN-aR-dependent induction of IL-10.
Endogenous Type I IFN Suppresses IL-1a,b Production
by Both iM and iDC Cells In Vivo
A probacterial role for endogenous type I IFNs has been demon-
strated previously in experiments in which Ifnar1/ mice were
shown to be less susceptible to Mtb infection (Manca et al.,
2005; Stanley et al., 2007). As shown in Figures 5A and 5B,
this decrease in bacterial burden was closely associated
with an increase in IL-1a,b production by pulmonary myeloid
cells.the proportion of iM or iDC cells expressing a given combination of cytokines
indicated by the colored boxes at the bottom of the x axis.
Data in all panels are representative of a minimum of three independent
experiments with three to six animals each.
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Figure 4. Type I and II IFNs Negatively
Regulate IL-1a and IL-1b Secretion by
Murine and Human Myeloid Cell Subsets In-
fected with Mtb
(A) Murine cytokines measured by ELISA in
supernatants of BMMFs and BMDCs from WT
mice after exposure to liveMtb (MOI:1) for 48 hr in
the presence or absence of recombinant murine
IL-27, IFN-g, or pICLC.
(B) IL-1b protein in supernatants of BMMFs
and BMDCs from WT, Ifnar1/, or Ifngr1/ mice
incubated with IFN-g or pICLC as indicated after
exposure to live Mtb (MOI:1).
(C) Human IL-1a and IL-1b measured by ELISA in
culture supernatants of human monocyte-derived
macrophages [MF]) or monocyte-derived DCs
from 21 healthy donors after 24 hr exposure to live
Mtb (MOI:5) in the presence or absence of pICLC
or the recombinant human cytokines IFN-b and
IFN-g. Horizontal lines indicate the median values.
Three asterisks denote significant (p < 0.0001)
differences compared to Mtb exposure alone.
(D) IL-1Ra protein in culture supernatants of
human MFs or DCs (top panels) and murine
BMMFs and BMDCs (bottom panels) incubated
as noted in (A) and (B).
(E) Cytokines in supernatants of BMMFs derived
from WT or Ifnar1/ mice after exposure to live
Mtb (MOI:1) for 24 hr.
(F) IL-10 protein in supernatants of WT BMMFs
incubated with increasing amounts of pICLC for
40 hr in the presence or absence of Mtb infection.
(G) IL-1b protein in supernatants of WT BMMFs
after exposure to live Mtb (MOI:1) for 24 hr incu-
bated with recombinant murine IFN-b in the pres-
ence or absence of neutralizing IL-10 mAb.
Murine data presented are the means ± SD and
representative of two to five independent experi-
ments. The asterisk denotes significant (p% 0.05)
differences compared toMtb exposure alone or as
indicated with connecting lines.
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IFNs Limit IL-1 Production during TuberculosisTo test whether endogenously induced type I IFNs can act
directly on IL-1a,b-producing cells during Mtb infection in vivo,
we generated mixed bone marrow chimeras allowing us to
compare Ifnar1/ and WT myeloid cells in the lungs of the
same animal. This approach controls internally for potential
differences in bacterial load, inflammatory milieu, and/or cellular
microenvironment. WT CD45.1,1 mice were lethally irradiated
and reconstituted with BM from WT (CD45.1,2) donors mixed
at a 1:1 ratio with Ifnar1/ CD45.2,2 donors (Figure 5C). The
mixed Ifnar1/, WT BM chimeras were then infected with Mtb1028 Immunity 35, 1023–1034, December 23, 2011 ª2011 Elsevier Inc.and 4 weeks later the frequency of
IL-1a,b DP cells within pulmonary WT or
Ifnar1/ cells was analyzed (Figure 5D).
Importantly, in both the iM and the iDC
cell subsets, the inability of Ifnar1/ cells
to receive type I IFN signals resulted in
a marked increase in the proportion of
IL-1a,bDP, even without Mtb restimula-
tion (Figures 5D and 5E). In addition, we
found that type I IFN signaling sup-
pressed iNOS production by iM and iDCcells, and in accordance with the in vitro data presented
above, it also induced IL-10 expression by myeloid cells in vivo
after Mtb infection (Figures 5F, 5G, and S5). In contrast, TNF-a
expression was not subject to type I IFN regulation. Furthermore,
phenotypic analysis revealed that type I IFN signaling influenced
expression of only a few IFN inducible and surface markers,
most notably CD206 and PD-L1 (Figure S3A). Together, these
data argued that ligation of the type I IFN receptor on each
of the two myeloid populations directly suppresses IL-1a,b
production in vivo.
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Figure 5. Endogenous Type I IFNs Suppress IL-1a,b Expression by Both iM and iDC Pulmonary Cell Subsets during Mtb Infection
(A) Pulmonary bacterial loads measured 4 weeks p.i. in WT or Ifnar1/ mice. The asterisk denotes significant (p% 0.05) difference compared to WT control.
(B) ICS for IL-1a,b by pulmonarymyeloid cells inWT or Ifnar1/mice 4weeks p.i. Data are representative of two independent experiments each involving three to
five mice per group. Numbers indicate mean percentage (±SD) of IL-1 producing cells in depicted gate.
(C) WT CD45.1,1 mice were lethally irradiated and reconstituted with equal ratios of WT (CD45.1,2) and Ifnar1/ (CD45.2,2) BM cells and infected with Mtb.
(D) Analysis of donor BM-derived CD11bpos myeloid cells 4 weeks p.i. in isolated lung cells marked by CD45.1 and CD45.2 expression (percentage ± SD) and
frequency of IL-1a,b expression by WT (white circles) or Ifnar1/ (KO, dark circles) total CD11bpos mononuclear myeloid cells after restimulation for 5 hr with
(Mtb) or without (unst.) Mtb. Each connecting line depicts an individual animal.
(E) Frequency of IL-1a,b expression by iM and iDC cell subsets in mixed Ifnar1/ BM chimeric mice.
(F and G) Frequencies of iNOS-, TNF-a-, and IL-10-expressing cells within pulmonary WT (white circles) or Ifnar1/ (KO, dark circles) iM cells (F) and within iDC
(G) cells.
Data in (A)–(F) are representative of three independent experiments with three to fivemice each. The asterisks denote significant (p% 0.05) differences compared
to WT controls (ns, not significant).
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IFNs Limit IL-1 Production during TuberculosisHost-Protective IFN-g Inhibits IL-1a,b Production
by iM Cells
Because in addition to type I IFNs, IFN-g also displayed potent
suppressive effects on IL-1 expression in vitro, we next used
the same mixed BM chimeric approach to determine whether
IFN-g signaling also regulates IL-1a,b production by myeloid
cells during Mtb infection in vivo. In these experiments, we con-
structed mixed Ifngr1/,WT BM chimeric mice and functionally
and phenotypically analyzed gene deficient or WT CD11bpos
subsets in the same animal for IFN-inducible surface marker
expression and their capacity to generate innate cytokines
(Figures 6 and S3B). Importantly, in the lungs of Mtb infected
chimeric mice, IL-1 production in the iM cell subset was mark-
edly increased in the absence of IFN-gR, whereas in iDC cells
no difference in IL-1a,b expression was observed between cells
of WT or Ifngr1/ origin (Figures 6A and 6B). In addition, we
found that expression of a number of IFN-inducible surface
markers were strongly affected by the absence of IFN-gR
signaling (Figure S3B). Interestingly, in the iDC cells, expression
of CD206 (macrophage mannose receptor), a surface molecule
recently shown to be a marker of TLR-induced monocyte-
derived DCs (Cheong et al., 2010), and IL-10R (CD210) were
both dependent on IFN-gR signaling (Figure S3B). As expected,
iNOS expression in both iM and iDC cell subsets was completelyImmabolished in IFN-gR-deficient cells compared to WT cells in the
same animal. Moreover, whereas TNF-a expression in both
myeloid subset was unaffected by the absence of IFN-gR,
IFN-g potently suppressed IL-10 production in iM but not iDC
cells (Figures 6C, 6D, and S5). Thus, while clearly a host-protec-
tive cytokine inMtb infection, IFNg in commonwith type I IFN can
also be anti-inflammatory suppressing IL-1a,b production by
pulmonary myeloid cells.
CD4+ T Cells Regulate IL-1 Expression during Mtb
Infection through Their Production of IFN-g
Th1 cells are amajor source of IFN-g duringMtb infection inmice
and therefore could be a key mediator of the suppression of IL-1
production observed in Ifngr1/, WT BM chimeric mice.
In support of this hypothesis, coculture of Mtb-infected
BMMFs for 3 days with naive TCR transgenic CD4 T cells recog-
nizing an epitope in the Mtb Ag85b protein (P25) resulted in
reduced IL-1b protein when compared to Mtb-infected cells
alone (Figure S4A). This reduction occurred in an IFN-g-depen-
dent manner and was antigen specific, given that addition of
CD4 T cells (OT-II) with an irrelevant specificity failed to suppress
IL-1b production. Interestingly, whereas addition of exogenous
IFN-g potently suppressed IL-1b expression by BMDCs (Fig-
ure 4A), coculture with P25 cells did not (Figure S4A). Moreover,unity 35, 1023–1034, December 23, 2011 ª2011 Elsevier Inc. 1029
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Figure 6. IFN-g Specifically Inhibits IL-1a,b Expression in the iM but not iDC Cell Subset
WT CD45.1,1 mice were lethally irradiated and reconstituted with equal parts WT (CD45.1,2) and Ifngr1/ (CD45.2,2) BM cells and infected with Mtb.
(A and B) Distribution of donor BM derived pulmonary CD11bpos myeloid cells 4 weeks p.i. marked by CD45.1 and CD45.2 expression (percentage ± SD) and
analysis of IL-1a,b expression by iM (A) and iDC (B) cell subsets gated on WT (WT, white circles) or Ifngr1/ (KO, dark circles) derived cells after stimulation for
5 hr with (Mtb) or without (unst.) Mtb. Each connecting line depicts an individual animal.
(C and D) Frequencies of iNOS-, TNF-a-, and IL-10-expressing cells within pulmonary WT (white circles) or Ifngr1/ (KO, dark circles), iM (C), and iDC (D) cell
subsets.
Data in all panels are representative of three independent experiments with three to five mice each. The asterisks denote significant (p % 0.05) differences
compared to WT controls (ns = not significant).
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IFNs Limit IL-1 Production during Tuberculosiswhen IFN-g signaling was disrupted on the BMDCs, P25 cells
were able to enhance, rather than suppress, IL-1b production
(Figure S4A). This finding suggests that CD4 T cells exert both
IFN-g-dependent-suppressive as well as IFN-g-independent-
inductive effects on IL-1 production by DCs.
We next designed adoptive transfer experiments to test the
hypothesis that duringMtb infection, CD4-derived IFN-g is suffi-
cient to mediate the previously observed suppression of IL-1
by iM cells in vivo. The approach utilized allowed us to study
APC-CD4 T cell interactions through targeted manipulation of
the genotype of the CD4+ T cells transferred into Tcra/ mice
(Figure S4B). WT or Ifng/ CD4+ T cells were adoptively trans-
ferred into Tcra/ mice prior to aerosol infection with Mtb and
bacterial loads were measured 4 weeks later (Figures S4B and
7A). Restimulated lung cells from Tcra/ mice reconstituted
with Ifng/ CD4+ T cells (Tcra/+Ifng/ CD4) secreted more
IL-1b when compared to lung cells from Tcra/ mice that
received WT CD4+ T cells (Tcra/+WT CD4) despite similar
pulmonary bacterial loads in the experimental groups at this
early time point (Figures 7A and 7B). Single-cell analysis of the
IL-1-producing subsets revealed that iM cells from Tcra/+
Ifng/ CD4 mice produced significantly more IL-1a,b when
compared to cells from Tcra/+WT CD4, even without restimu-
lation ex vivo (Figure 7C). Moreover, consistent with our findings
in mixed BM chimeric mice, IL-1a,b production by iDC cells was
unaffected in the absence of CD4+ T cell derived IFN-g whereas1030 Immunity 35, 1023–1034, December 23, 2011 ª2011 Elsevier IniNOS expression was critically dependent on IFN-g from this
source (Figures 7D, S4C, and S5). These findings thus reveal
an anti-inflammatory function for Th1 cell-derived IFN-g in
modulating IL-1 production by myeloid cells in vivo during Mtb
infection.
DISCUSSION
Although myeloid cells are the primary targets of mycobacterial
infection (Wolf et al., 2007), they are also pivotal effector cells
that mediate control of intracellular bacterial growth and orches-
trate the inflammatory response to the pathogen. Previous
studies have emphasized the roles of myeloid-derived iNOS
and TNF-a as important effector molecules for bacterial control
of Mtb in the mouse model (Saunders et al., 2004; Sko¨ld and
Behar, 2008). We found that IL-1a and IL-1b each have critical
nonredundant functions in preventing host mortality but appear
to cooperate in mediating IL-1R-dependent bacterial control.
Indeed, a role for IL-1a in host resistance to Mtb is supported
by a recent study in which the induction of autoantibodies
against the cytokine resulted in increased mortality during
chronic Mtb infection (Guler et al., 2011).
IL-1a and IL-1b are also traditionally regarded as myeloid cell-
derived proinflammatory cytokines. Their in vivo source during
Mtb infection had not been examined, and therefore it was
unclear whether IL-1 derives from the same cell populationsc.
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Figure 7. CD4+ T Cell-Derived IFN-g Is Sufficient to Suppress IL-1
Production by iM Cells In Vivo
(A) Bacterial loads were measured in lungs of WT, Tcra/, and Tcra / mice
reconstituted with WT or Ifng/ CD4+ T cells. The asterisk denotes significant
(p% 0.05) differences compared to WT controls (ns = not significant).
(B) Pulmonary single-cell suspensions from animals in the indicated experi-
mental groups were incubated withMtb and IL-1b was measured by ELISA in
the culture supernatant after 8 hr. Data shown are derived from a pool of three
to five mice per group.
(C and D) ICS for IL-1a and IL-1b expression by iM (C) and iDC (D) cell subsets
in lungs of Tcra/ mice reconstituted with WT (left plot, white squares) or
Ifng/ (right plot, dark squares) CD4+ T cells and frequencies of IL-1a,b
expression after stimulation for 5 hr with (Mtb) or without (unst.) Mtb.
Data in all panels are representative of two independent experiments with
three to five mice each. The asterisks denote significant (p% 0.05) differences
compared to WT controls (ns, not significant).
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IFNs Limit IL-1 Production during Tuberculosisthat produce the major iNOS and TNF-a effector molecules.
Similarly, the mechanisms that regulate IL-1 expression during
Mtb infection in vivo are poorly understood, particularly the
possible role of other cytokine pathways in controlling IL-1
production.
In characterizing the innate immune sources of IL-1a and
IL-1b, we identified three myeloid cell types (iM cells, iDC cells,
and neutrophils) differentially producing the cytokines in the
lungs of Mtb-infected mice. Surprisingly, neutrophils did notImmproduce significant amounts of IL-1b. Given our previous find-
ings on the caspase-1-independent processing of IL-1b in vivo
during Mtb infection (Mayer-Barber et al., 2010), the neutrophil
represented a logical candidate for the cellular source of IL-1b
during Mtb infection. Although not producing pro-IL-1b, neutro-
phils could still play a role in the IL-1 response toMtb in mice by
secreting proteases that would cleave extracellular pro-IL-1b
(Dinarello, 2010).
A key finding of the present study is that in lungs of Mtb-
infected mice, two major CD11bpos iM and iDC cell subpopula-
tions coproduce IL-1a and IL-1b at the single-cell level. These
cells also produce large amounts of the host-protective media-
tors iNOS and TNF-a. The iM (Ly6Chi, Cd11cneg, CD282int, and
CD13neg) cells represent a single mononuclear phagocyte popu-
lation and produce predominantly IL-1a, IL-1b, and TNF-a. They
display phenotypic markers characteristic of inflammatory
monocytes-macrophages previously described in nonlymphoid
tissue (Dunay et al., 2008; Geissmann et al., 2010; Varol et al.,
2009). In addition they share similar functional properties, e.g.,
IL-10 and iNOS production, with myeloid-derived suppressor
cells that have been extensively studied in long-term unresolved
pathological conditions such as chronic infections, inflamma-
tion, and cancer (Biswas and Mantovani, 2010).
In contrast, the iDC (CD11cpos, Ly6Cneg-int, CD13pos, and
CD282int,hi) cells express high levels of MHCII, CD80, and
CD86 as well as additional markers associated with antigen
presentation and APC-T cell interactions and probably reflect
pulmonary DCs. On the basis of their cytokine expression
profiles, these cells contain at least two functionally distinct DC
subsets, one producing IL-1a,b (CD282hi, Ly6Cpos) in con-
cert with iNOS, TNF-a, and IL-10 and the second producing
IL-12,23p40 (CD282int, Ly6Cneg). The IL-1a,b-producing iDC
cells closely resemble monocyte-derived inflammatory DCs, an
iNOS- and TNF-a-producing DC subset that has been previously
implicated in murine resistance to intracellular bacteria, para-
sites, or viruses and in human psoriasis (De Trez et al., 2009;
Lin et al., 2008; Lowes et al., 2005; Serbina et al., 2003). In
contrast, the IL-12,23 p40-expressing iDC cells are similar to
a subset of conventional DCs previously characterized in lung
(GeurtsvanKessel and Lambrecht, 2008). Moreover, both
IL-1a,b- and IL-12,23 p40-producing DC subsets were detected
in the lung draining lymph node (data not shown), and it is
possible that these two functionally separate DC populations
play important yet distinct roles in T helper cell differentiation
during Mtb infection. Thus, IL-12 is required for the generation
of IFN-g-producing Th1 cells (Cooper et al., 2011), whereas as
described here IL-17 protein and Th17 cell responses (data not
shown) were diminished in lungs of IL-1-deficient animals in-
fected with Mtb. Such a functional division of labor between
DC populations could play a key factor in determining Th cell
lineage fate decisions in lymph nodes and peripheral tissue sites
during infection.
Inflammasome activation is not required for host resistance
and IL-1b processing duringMtb infection in vivo (Mayer-Barber
et al., 2010), so we focused on mechanisms that could regulate
the induction and/or function of both IL-1a and IL-1b. Previous
in vitro studies had found that type I and type II IFNs modulate
pro-IL-1b expression (Guarda et al., 2011; Guarda et al., 2009;
Masters et al., 2010; Novikov et al., 2011). To investigate theunity 35, 1023–1034, December 23, 2011 ª2011 Elsevier Inc. 1031
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IFNs Limit IL-1 Production during Tuberculosisrole of IFNs in regulating IL-1a,b production in vivo at the cellular
level, we utilized mixed BM chimeras that allowed the side-by-
side comparison of WT and gene-deficient populations in the
same animal.
Type I IFNs had a major suppressive effect on both IL-1a and
IL-1b production by the iM and iDC cells in the lungs of Mtb-
infected mice. The precise mechanism by which IFN-aR sig-
naling mediates suppression of IL-1a,b expression by these
myeloid subsets is unclear. In a recent study by Guarda et al.
(2011), it was shown that type I IFN inhibits LPS induced pro-
IL-1b expression via IL-10. Moreover, IL-10 has been shown to
promote susceptibility toMtb in mice (Redford et al., 2010; Red-
ford et al., 2011; Turner et al., 2002). Here, we implicate IL-10 in
type I IFN-mediated IL-1 suppression in vitro during Mtb infec-
tion and extend this observation in vivo by showing that IL-10
production by pulmonary iM and iDC cells during Mtb infection
is type I IFN dependent. Furthermore, we show that this IL-10
production is limited primarily to IL-1a,b-expressing cells.
Although IL-10 may be involved indirectly in the type I IFN
mediated suppression of IL-1 in vivo, our mixed BM chimera
experiments clearly argue that IFN-aR-signals act directly on
the cytokine-producing cells to inhibit IL-1a,b expression in the
lungs of Mtb-infected mice.
Although inhibition of IFNgR (CD119) expression has been
implicated in the probacterial effects of type I IFNs (Rayamajhi
et al., 2010b), we failed to observe IFN-aR-mediated downregu-
lation of CD119 duringMtb infection. Rather, our data reveal that
type I IFNs act onmultiple innate immune cell types to coordinate
a multifaceted anti-inflammatory response to Mtb infection,
simultaneously suppressing IL-1a,b and iNOS while promoting
expression of immunosuppressive IL-10 and IL-1Ra. There is
now growing evidence that induction of type I IFN directly serves
the pathogen as a host evasion mechanism to promote bacterial
survival (Rayamajhi et al., 2010a; Trinchieri, 2010), and our find-
ings argue that this may stem from combined repression of
a collection of critical host-protective pathways in which IL-1
should now be included as a member.
In addition to type I IFNs, we demonstrated that type II IFN
(IFN-g) also modulates IL-1 expression in vivo during Mtb infec-
tion. However, we found that IFN-g suppressed IL-1 a,b produc-
tion in the iM but not the iDC cell population. This observation
was unexpected given that both subsets not only expressed
IFN-gR1 but were also highly responsive to IFN-g during Mtb
infection as evidenced by the ablation of iNOS expression in
the Ifngr1/ cells. There are several possible explanations for
this differential regulation. First, the iM cell subset represents
a single cellular population, whereas iDC cells comprise multiple
subpopulations. In the absence of IFN-gR expression, the iDC
cell subpopulations underwent major phenotypic changes,
raising the possibility of selective outgrowth and/or recruitment
of receptor-deficient cells under these conditions. Second, the
two subsets may integrate IFN-gR-mediated signals in a qualita-
tively different fashion (Hu et al., 2006; Masters et al., 2010).
Lastly, the differential regulation of IL-1 production by inflamma-
tory monocytes-macrophages and DCs could reflect opposing
activities of Th1 cells on DCs. CD4 T cells have been shown to
be capable of both suppressing and inducing IL-1b expression
in myeloid cells (Guarda et al., 2009; Jayaraman et al., 2010).
Indeed, our in vitro studies with BMDCs support the hypothesis1032 Immunity 35, 1023–1034, December 23, 2011 ª2011 Elsevier Inthat CD4 T cells suppress IL-1b via IFN-g while simultaneously
enhancing its expression through an IFN-g-independent mecha-
nism, as previously proposed with Tim-3 (Jayaraman et al.,
2010). These two counterregulatory effects mediated by Th1
cells may cancel each other out, thereby explaining the apparent
lack of IFN-g-mediated suppression of IL-1a,b production in the
iDC cell subset in vivo.
An intriguing paradox raised by our findings concerns the
apparently opposing functions of IFN-g in mediating host resis-
tance to this pathogen and in suppressing the host-protective
cytokines IL-1a and IL-1b. On the one hand, IFN-g promotes
inflammation by inducing upregulation of MHC class II and
iNOS in iM and iDC cells while suppressing IL-10 expression in
iM cells. On the other hand, IFN-gmediates its anti-inflammatory
effects by suppressing IL-1a,b production in iM cells, upregulat-
ing IL-10R expression on iDC cells, and acting as the principal
inducer of the inhibitory ligand PD-L1. Our findings provide a
context for the role of IL-1 in the complex proinflammatory and
suppressive pathways simultaneously induced by IFN-g: in
contrast to other host-protective factors induced by IFN-g, IL-1
is actively suppressed.
Collectively, our data demonstrate that the host detrimental
type I IFN and host protective IFN-g both downmodulate
IL-1a,b production. This situation may have evolved to mutually
benefit the bacteria and the host by simultaneously inhibiting
IL-1-dependent control of infection while limiting immunopa-
thology. Although the in vivo findings presented here derive
exclusively from studies in the murine model, their relevance to
human Mtb infection is supported by the recent work of Berry
et al. (2010) in which a transcriptional profile marked by type I
and II IFN-induced genes was found to correlate with disease
severity in patients. Our data linking IFN signaling with IL-1
suppression provide a testable hypothesis for explaining this
correlation between IFN expression and human disease.EXPERIMENTAL PROCEDURES
Mice and Mtb Infections
C57BL6 (WT, B6) and Ifngr1/ mice were purchased from Taconic Farms
(Hudson, NY) and Jackson Laboratories (Bar Harbor, ME), respectively.
B6.SJL (CD45.1,1), Tcra/, Ifng/, Ifnar1/, Il1r1/, and OT-II mice were
obtained through a supply contract between the National Institute of Allergy
and Infectious Diseases (NIAID) and Taconic Farms and were backcrossed
to B6 for a minimum of ten generations. Ag85b-specific P25 TCR transgenic
mice, originally generated by Takatsu and colleagues were kindly provided
by J. Ernst (NYU). Il1a/, Il1b/, and Il1a/Il1b/ mice were originally
derived by Y. Iwakura (Tokyo University) and generously supplied by T. Merkel
(FDA). All animals were maintained in an AALAC-accredited BSL2 or BSL3
facilities at the NIH and experiments performed in compliance with an animal
study proposal approved by the NIAID Animal Care and Use Committee.
Aerosol infection with the H37Rv strain of Mtb (100-150 CFU/mouse unless
noted otherwise) and determination of lung bacterial growth were performed
as previously described (Mayer-Barber et al., 2010).
Macrophage and DC Differentiation and In Vitro Cultures
We cultured murine BM cells for 7 days in either 15% GM-CSF media to
generate BMDC or 30% L929 supernatant media to differentiate BMMFs
and then exposed them to H37Rv at a multiplicity of infection of one (MOI:1)
in the presence or absence of 30 ng/ml IL-27 (Ebioscience, San Diego, CA),
200 U/ml IFN-g (Ebioscience), 30 ng/ml IL-10 (Ebioscience), 30 ng/ml IFN-b
(R&D Systems, Minneapolis, MN), and 20 mg/ml pICLC (kindly provided by
A. Salazar, Oncovir, Inc.) for 24–48 hr and supernatants were harvested. Inc.
Immunity
IFNs Limit IL-1 Production during Tuberculosissome experiments, P25 or OT-II CD4 T cells were enriched from spleen and
lymph nodes of uninfected mice by magnetic bead separation (Miltenyi
Biotech, Auburn, CA) and for 60hr coculture at a ratio of 2:1 (T cells:BM-
derived cells).
Human elutriated monocytes were obtained from peripheral blood of 21
healthy CMV negative donors. MFs were generated by culturing monocytes
with media containing M-CSF (60 ng/ml) for 7 days and DCs after 5 days of
culture in the presence of GM-CSF (800 U/ml) and IL-4 (1000 U/ml); the cells
were subsequently matured for 48 hr with TNF-a (20 ng/ml). Fresh media
with indicated growth factors was added every 48 hr. Cells were exposed
to H37Rv (MOI = 5) in the presence or absence IFN-g (10 ng/ml), IFN-
b (10 ng/ml), or pICLC (10 mg/ml) for 24 hr. All recombinant human cytokines
were from Peprotech (Rocky Hill, NJ).
Cytokine and Nitric Oxide Measurements in Culture Supernatants
and Biological Fluids
Murine and human cytokine concentrations in culture supernatants were
quantitated with commercial ELISA kits (R&D Systems, Minneapolis, MN).
Bronchoalveolar lavage (BAL) fluid and cell-free lung homogenates were ob-
tained and cytokines and nitric oxide measured as described previously
(Mayer-Barber et al., 2010).
Flow Cytometry
Abs against mouse surface antigens and cytokines were purchased from
Ebioscience, Biolegend (San Diego, CA), AbD Serotec (Raleigh, NC), and
BD PharMingen (San Diego, CA) and used in 12-color flow cytometry either
biotinylated or directly conjugated. The Abs used were directed against
Ly6C (clone AL-21), Ly6G (1A8), CD13 (R3-63), CD11c (HL3 and N418),
CD282 (6C2), CD68 (FA-11), CD45.1 (A20), CD45.2 (104), I-Ab (M5/
114.15.2), IL-1a PE (ALF-161), IL-1b APC (polyclonal and replacement pro-
IL-1b monoclonal NJTEN3), iNOS (polyclonal), IL-12,23 p40 (C15.6), TNF-
a (MP6-XT22), IL-10 (JES5-16E3), CD11b (M1/70), TCR-b (H57-597), CD19
(6D5), NK1.1 (PK136), 7/4 (7/4), IL10R/CD210 (1B1.3a), CD206 (MR5D3),
IFN-gRI/CD119 (GR20), CD14 (Sa14-2), PDL-1/CD274 (MIH5), Sca-1(D7),
and CD16/32 (93). Biotinylated antibodies were detected with streptavidin-
conjugated Qdot 605 from Molecular Probes-Invitrogen (Carlsbad, CA).
Ultraviolet fixable live-dead cell stain was purchased from Molecular
Probes-Invitrogen and used in accordance with the manufacturer’s pro-
tocol. All samples were acquired on a LSRII flow cytometer (BD Bio-
sciences, San Jose, CA) and analyzed with FlowJo software (Three Star,
Ashland, OR).
Isolation and Restimulation of Myeloid Cells from Lung Tissue
Perfused lungs from infected mice were cut into 1–2 mm pieces and
subsequently digested with Liberase Cl (0.4 mg/ml in PBS; Roche-Diagnos-
tics, Indianapolis, IN). The reaction was stopped after 30–45 min with an equal
volume of fetal calf serum. Digested lung was fully dispersed by passage
through a 100 mmpore size cell strainer and an aliquot was removed for bacte-
rial load measurements. Isolated cells were then washed, counted, and resus-
pended in media containing monensin (0.1%, Ebioscience) in the presence or
absence of 100 ug/ml irradiatedMtb H37Rv at 13 106 cells per well in 96-well
plates and incubated at 37C, 5% CO2. Five hours later, cells were surface
stained, fixed, permeabilized, and ICS performed.
Preparation of Mixed BM Chimeric Mice
B6.SJL (CD45.1,1) mice were lethally irradiated (950 rad) and reconstituted
with a total of 107 donor BM cells from C57BL/6 CD45.1,2 wild-type (WT)
mice mixed at equal parts with BM cells from CD45.2,2 mice deficient (KO)
in either IFN-gR1or IFN-aR1.Micewere allowed to reconstitute for 8–10weeks
before aerosol infection with H37Rv.
T Cell Isolation and Adoptive Transfer
CD4 T cells for adoptive transfer were enriched from the spleen and lymph
nodes of uninfected B6 or Ifng/ mice by magnetic bead separation to
90%–95% purity, according to the manufacturer’s protocol (Miltenyi Biotec)
and injected intravenously into Tcra/ mice (4 3 106 cells/animal) 1–7 days
prior to aerosol infection with H37Rv.ImmStatistical Analyses
The statistical significance of differences between data groups was deter-
mined with the Mann-Whitney test or the Wilcoxon matched pairs test (mixed
BM chimera experiments).SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and can be found with this
article online at doi:10.1016/j.immuni.2011.12.002.
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